Latest Transformation News

Viva Leisure has grown from 29 gyms in 2019 to over 480 locations, leveraging proprietary technology and a multi-brand strategy to lead fitness innovation across Australia and beyond.

Viva Leisure has launched a refreshed corporate brand and published 'The Viva Story,' outlining its transformation into a global, technology-driven fitness ecosystem.

INOVIQ Limited has announced a breakthrough in its cancer treatment program, with its CAR-exosome therapy killing 88% of triple negative breast and lung cancer cells in laboratory studies. This innovation could pave the way for faster, safer, and more accessible cancer therapies.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

Provaris Energy and Yinson have completed the design of a groundbreaking large-scale liquid CO2 tank for maritime use and are forming a joint venture to commercialize this innovation, aiming to scale carbon capture supply chains and reduce costs.

Terramin Australia reports progress on its Tala Hamza Zinc Project amid Algeria's landmark mining reforms that raise foreign ownership limits and streamline permits, potentially reshaping its investment landscape.

Ark Mines has launched a detailed metallurgical improvement program at its Sandy Mitchell Rare Earth and Heavy Minerals project, aiming to refine processing techniques and expand its resource base. The work supports a Pre-Feasibility Study due early next year.

Avenira Limited has secured Northern Territory Government approval for its Wonarah Direct Shipping Ore Mine Management Plan, paving the way for first ore shipment by Q4 2025. The project includes infrastructure development and exploration drilling to support future beneficiation.

Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.

Clarity Pharmaceuticals has partnered with SpectronRx to manufacture and distribute its lead prostate cancer diagnostic, Cu-64 SAR-bisPSMA, at commercial scale across the US. This agreement sets the stage for a seamless launch pending FDA approval.

Wrkr Ltd has completed a pivotal pilot of its employer services platform with Rest and MUFG Retirement Services, setting the stage for streamlined Payday Super implementation ahead of the July 2026 deadline.

RLF AgTech has secured exclusive rights to distribute AXIOMA Biologicals’ advanced biostimulant products across Australia, China, and Asia, marking a strategic move into the biologicals market segment.